These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of potential delayed hemolytic transfusion reaction in two sickle cell patients using intravenous immunoglobulins and steroids before and after red blood cell exchange with antigen positive units and review literature. Shold J, Dasgupta A, Ye Z. Transfus Apher Sci; 2024 Jun; 63(3):103920. PubMed ID: 38570214 [Abstract] [Full Text] [Related]
4. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Win N, New H, Lee E, de la Fuente J. Transfusion; 2008 Jun; 48(6):1231-8. PubMed ID: 18373500 [Abstract] [Full Text] [Related]
6. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report. Win N, Lee E, Needs M, Chia LW, Stasi R. Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101 [Abstract] [Full Text] [Related]
13. Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease. Shaulov A, Rund D, Filon D, Nachmias B, Khalili A, Manny N, Zelig O. Transfusion; 2023 May; 63(5):1100-1106. PubMed ID: 36866433 [Abstract] [Full Text] [Related]
18. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab. Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F. Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065 [Abstract] [Full Text] [Related]
19. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease. Fasano RM, Miller MJ, Chonat S, Stowell SR. Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199 [Abstract] [Full Text] [Related]